Halozyme Therapeutics, Inc. (BMV:HALO)
Mexico
· Delayed Price · Currency is MXN 1,017.50
+59.50 (6.21%)
At close: May 16, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Total Net Product Sales | 322.95M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Net Product Sales Growth | 8.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Revenue Under Collaborative Agreements | 142.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Revenue Under Collaborative Agreements Growth | 49.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalties | 618.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalties Growth | 31.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales of Proprietary Products | 167.71M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales of Proprietary Products Growth | 21.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales of Bulk rHuPH20 | 102.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales of Bulk rHuPH20 Growth | -1.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales of Device Partnered Products | 52.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sales of Device Partnered Products Growth | -7.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| United States |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other Foreign Countries Revenue (Pre-FY2023) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other Foreign Countries Revenue (Pre-FY2023) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Belgium |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Belgium Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other Foreign Countries Revenue (Post-FY2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other Foreign Countries Revenue (Post-FY2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|